Form 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report Of Foreign Private Issuer
Pursuant To Rule 13a-16 Or 15d-16 Of
The Securities Exchange Act Of 1934
For the month of November, 2012
Commission File Number: 001-14950
ULTRAPAR HOLDINGS INC.
(Translation of Registrant’s Name into English)
Avenida Brigadeiro Luis Antonio, 1343, 9º Andar
São Paulo, SP, Brazil 01317-910
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
|
Form 20-F
|
X
|
Form 40-F
|
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
|
Yes
|
No
|
X
|
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
|
Yes
|
No
|
X
|
Indicate by check mark whether by furnishing the information contained in this Form, the Registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
|
Yes
|
No
|
X
|
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A
ULTRAPAR HOLDINGS INC.
TABLE OF CONTENTS
|
ITEM
|
|
1.
|
Market Announcement dated November 1, 2012
|
 |
ULTRAPAR PARTICIPAÇÕES S.A.
Publicly Listed Company
CNPJ nº 33.256.439/0001- 39
NIRE 35.300.109.724
|
Oxiteno concludes the acquisition of American Chemical in Uruguay
São Paulo, Brazil, November 1st, 2012 – In addition to the Market Announcement released on May 28th, 2012, Ultrapar Participações S.A. hereby announces that it closed today, through its subsidiary Oxiteno, after completion of the due diligence process and the compliance with the conditions precedent of the sale and purchase agreement, the purchase of 100% shares of American Chemical I.C.S.A., a Uruguayan specialty chemicals company.
The total acquisition value was US$ 74 million, including the assumption of net debt in the amount of US$ 18 million, subject to the customary working capital and net debt final adjustments on the closing date.
Through the acquisition of American Chemical, Oxiteno continues the international expansion of its activities, started in 2003 and based on its deep knowledge of the technology for production and application of surfactants and specialty chemicals and on its strong relationship with its clients.
André Covre
Chief Financial and Investor Relations Officer
Ultrapar Participações S.A.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: November 1, 2012
|
ULTRAPAR HOLDINGS INC.
|
||
|
By:
|
/s/ André Covre
|
|
|
Name:
|
André Covre
|
|
|
Title:
|
Chief Financial and Investor Relations Officer
|
|
(Market Announcement dated November 1, 2012)